ST segment resolution as a tool for assessing the efficacy of reperfusion therapy.

[1]  E. Antman,et al.  Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. , 2001, The American journal of cardiology.

[2]  P. Armstrong,et al.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. , 2001 .

[3]  H. Pereira,et al.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial , 2001, The Lancet.

[4]  K. Wegscheider,et al.  Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial. , 2001, European heart journal.

[5]  E. Antman,et al.  Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial. , 2001, American heart journal.

[6]  E. Antman,et al.  Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II. , 2000, The American journal of cardiology.

[7]  E. Antman,et al.  Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. , 2000, European heart journal.

[8]  E. Antman,et al.  TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy , 2000, Circulation.

[9]  E. Antman,et al.  Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram. , 2000, American heart journal.

[10]  E. Antman,et al.  Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[11]  W. Dassen,et al.  Angiographic assessment of prospectively determined non-invasive reperfusion indices in acute myocardial infarction , 2000, Heart.

[12]  M. de Belder,et al.  Failure of thrombolysis: experience with a policy of early angiography and rescue angioplasty for electrocardiographic evidence of failed thrombolysis , 2000, Heart.

[13]  S. Ellis,et al.  Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences. , 2000, American heart journal.

[14]  T Akasaka,et al.  Relation of phasic coronary flow velocity characteristics with TIMI perfusion grade and myocardial recovery after primary percutaneous transluminal coronary angioplasty and rescue stenting. , 2000, Circulation.

[15]  H. Dauerman,et al.  Resolution of coronary thrombus with rescue stenting. , 2000, The American journal of cardiology.

[16]  H. White,et al.  ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy. , 2000, Circulation.

[17]  R. Califf,et al.  Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis. Reexamining the "gold standard" for myocardial reperfusion assessment. , 2000, Journal of the American College of Cardiology.

[18]  E. Antman,et al.  ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. , 2000, The American journal of cardiology.

[19]  E. Antman,et al.  Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. , 2000, Circulation.

[20]  C M Gibson,et al.  Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.

[21]  Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group. , 2000, Circulation.

[22]  Ric,et al.  CARDIAC TROPONIN T LEVELS FOR RISK STRATIFICATION IN ACUTE MYOCARDIAL ISCHEMIA , 2000 .

[23]  R. Califf,et al.  Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. , 1999, The American journal of cardiology.

[24]  D. Freimark,et al.  The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. , 1999, Journal of the American College of Cardiology.

[25]  K. Wegscheider,et al.  Comparison of the predictive value of ST segment elevation resolution at 90 and 180 min after start of streptokinase in acute myocardial infarction. A substudy of the hirudin for improvement of thrombolysis (HIT)-4 study. , 1999, European heart journal.

[26]  E. Antman,et al.  Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. , 1999, Journal of the American College of Cardiology.

[27]  R. Califf,et al.  Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries. , 1999, The American journal of cardiology.

[28]  K. Wegscheider,et al.  Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial. , 1999, Journal of the American College of Cardiology.

[29]  J. Habbema,et al.  Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trial. , 1999, American heart journal.

[30]  E. Antman,et al.  Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. , 1999, Journal of the American College of Cardiology.

[31]  E. Antman,et al.  Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. , 1999, Circulation.

[32]  C. Vrints,et al.  Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. , 1999, Circulation.

[33]  A. Kastrati,et al.  Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. , 1998, Circulation.

[34]  R. Califf,et al.  Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: results of the Platelet Aggregation Receptor Antagonist Dose Investigation and Reperfusion Gain in Myocardial Infarction (PARADIGM) trial. , 1998, Journal of the American College of Cardiology.

[35]  D. Freimark,et al.  The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion. , 1998, Journal of the American College of Cardiology.

[36]  D. Antoniucci,et al.  Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. , 1998, The American journal of cardiology.

[37]  Y. Shimono,et al.  Assessment of "microvascular no-reflow phenomenon" using technetium-99m macroaggregated albumin scintigraphy in patients with acute myocardial infarction. , 1998, Journal of the American College of Cardiology.

[38]  H. Suryapranata,et al.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. , 1998, Circulation.

[39]  D. Holmes,et al.  Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. GUSTO-1 Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1998, Journal of the American College of Cardiology.

[40]  H. White,et al.  Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction. , 1998, Journal of the American College of Cardiology.

[41]  Katherine C. Wu,et al.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. , 1998, Circulation.

[42]  R. Califf,et al.  Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy. , 1998, Journal of the American College of Cardiology.

[43]  E. Topol.  A comparison of reteplase with alteplase for acute myocardial infarction. , 1998, The New England journal of medicine.

[44]  M. Farrer,et al.  Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes , 1997, Heart.

[45]  Felix Zijlstra,et al.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction , 1997, The Lancet.

[46]  M. Nakamura,et al.  Prognostic value of slow resolution of ST-segment elevation following successful direct percutaneous transluminal coronary angioplasty for recovery of left ventricular function. , 1997, The American journal of cardiology.

[47]  E. Braunwald,et al.  Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial. , 1997, The American journal of cardiology.

[48]  T. Investigators,et al.  A comparison of reteplase with alteplase for acute myocardial infarction , 1997 .

[49]  R. Califf,et al.  Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. , 1997, Circulation.

[50]  T. Böhm,et al.  Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. , 1997, European heart journal.

[51]  M. Noble,et al.  Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. , 1996, Circulation.

[52]  P. Armstrong,et al.  Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. , 1996, European heart journal.

[53]  F. Verheugt,et al.  Reocclusion: the flip side of coronary thrombolysis. , 1996, Journal of the American College of Cardiology.

[54]  G. Wagner,et al.  Serum myoglobin for the early non-invasive detection of coronary reperfusion in patients with acute myocardial infarction. , 1996, European heart journal.

[55]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[56]  E. Braunwald,et al.  Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Thrombolysis in Myocardial Infarction Investigators. , 1995, The American journal of cardiology.

[57]  K Wegscheider,et al.  Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial. , 1995, Journal of the American College of Cardiology.

[58]  P. Steg,et al.  A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group. Prospective Evaluation of Reperfusion Markers. , 1995, Circulation.

[59]  F. Van de Werf,et al.  Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up. , 1995, Circulation.

[60]  P. Buszman,et al.  Use of changes in ST segment elevation for prediction of infarct artery recanalization in acute myocardial infarction. , 1995, European heart journal.

[61]  H. Wellens,et al.  Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. , 1995, The American journal of cardiology.

[62]  R. Califf,et al.  Noninvasive assessment of speed and stability of infarct-related artery reperfusion: results of the GUSTO ST segment monitoring study. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, Journal of the American College of Cardiology.

[63]  J. Kalbfleisch,et al.  More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators. , 1995, Circulation.

[64]  J. Ruidavets,et al.  Trends in acute myocardial infarction prognosis and treatment in southwestern France between 1985 and 1990 (the MONICA Project-Toulouse). , 1995, The American journal of cardiology.

[65]  E. Topol,et al.  Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. , 1994, Circulation.

[66]  J. Ishii,et al.  Early detection of successful coronary reperfusion based on serum myoglobin concentration: comparison with serum creatine kinase isoenzyme MB activity. , 1994, American heart journal.

[67]  A. Maggioni,et al.  A simple electrocardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent. A Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2)-Derived Analysis. , 1994, Journal of the American College of Cardiology.

[68]  K. Wegscheider,et al.  Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. , 1994, Journal of the American College of Cardiology.

[69]  R. Califf,et al.  Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study , 1994, Coronary artery disease.

[70]  R. Califf,et al.  Comparison of continuous ST-segment recovery analysis with methods using static electrocardiograms for noninvasive patency assessment during acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 7 Study Group. , 1994, The American journal of cardiology.

[71]  H. Oda,et al.  Additional ST-segment elevation immediately after reperfusion and its effect on myocardial salvage in anterior wall acute myocardial infarction. , 1994, The American journal of cardiology.

[72]  Gusto Angiographic Investigators.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[73]  R. Califf,et al.  Noninvasive detection of reperfusion after thrombolysis based on serum creatine kinase MB changes and clinical variables. TAMI 7 Study Group. Thrombolysis and Angioplasty in Myocardial Infarction. , 1993, American heart journal.

[74]  T. Linderer,et al.  Sudden increase of the ST segment elevation at time of reperfusion predicts extensive infarcts in patients with intravenous thrombolysis. , 1993, American heart journal.

[75]  R. Califf,et al.  Continuous 12‐Lead ST‐Segment Recovery Analysis in the TAMI 7 Study Performance of a Noninvasive Method for Real‐Time Detection of Failed Myocardial Reperfusion Detection of Failed Myocardial Reperfusion , 1993, Circulation.

[76]  G. Wagner,et al.  Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction. , 1993, American Journal of Cardiology.

[77]  U. Tebbe,et al.  Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. , 1993, Journal of the American College of Cardiology.

[78]  S. Hohnloser,et al.  Analysis of Creatine Kinase, CK‐MB, Myoglobin, and Troponin T Time‐Activit Curves for Early Assessment of Coronary Artery Reperfusion After Intravenous Thrombolysis , 1993, Circulation.

[79]  R. Califf,et al.  Continuously updated 12-lead ST-segment recovery analysis for myocardial infarct artery patency assessment and its correlation with multiple simultaneous early angiographic observations. , 1993, The American journal of cardiology.

[80]  P. Shah,et al.  Angiographic validation of bedside markers of reperfusion. , 1993, Journal of the American College of Cardiology.

[81]  Y. Shimono,et al.  Is ST segment re-elevation associated with reperfusion an indicator of marked myocardial damage after thrombolysis? , 1993, Journal of the American College of Cardiology.

[82]  A. Kitabatake,et al.  Lack of Myocardial Perfusion Immediately After Successful Thrombolysis: A Predictor of Poor Recovery of Left Ventricular Function in Anterior Myocardial Infarction , 1992, Circulation.

[83]  J. Anderson,et al.  Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction. , 1992, Journal of the American College of Cardiology.

[84]  H. Hellstrom.  Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. , 1991, Circulation.

[85]  S. Hohnloser,et al.  Assessment of coronary artery patency after thrombolytic therapy: accurate prediction utilizing the combined analysis of three noninvasive markers. , 1991, Journal of the American College of Cardiology.

[86]  K. Allman,et al.  The unstable ST segment early after thrombolysis for acute infarction and its usefulness as a marker of recurrent coronary occlusion. , 1991, The American journal of cardiology.

[87]  K. Lee,et al.  Changes in standard electrocardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. , 1990, The American journal of cardiology.

[88]  R. Califf,et al.  Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. , 1990, Journal of the American College of Cardiology.

[89]  H. Hod,et al.  Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction. , 1990, British heart journal.

[90]  F. Van de Werf,et al.  Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator. , 1990, Circulation.

[91]  R. Califf,et al.  Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. , 1990, Circulation.

[92]  D. Reid,et al.  Reduction in ST segment elevation after thrombolysis predicts either coronary reperfusion or preservation of left ventricular function. , 1990, British heart journal.

[93]  Harold L Skaggs,et al.  Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis , 1988 .

[94]  E. Topol,et al.  Prediction of infarct coronary artery recanalization after intravenous thrombolytic therapy. , 1987, The American journal of cardiology.

[95]  W. Ganz.  Intracoronary thrombolysis in evolving myocardial infarction. , 1981, Annals of internal medicine.

[96]  E. Braunwald,et al.  Evaluation of Precordial Electrocardiographic Mapping as a Means of Assessing Changes in Myocardial Ischemic Injury , 1975, Circulation.

[97]  P. Libby,et al.  Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. , 1972, The Journal of clinical investigation.

[98]  P. Libby,et al.  Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. , 1972, The American journal of cardiology.

[99]  J. Covell,et al.  Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions , 1971, Circulation.

[100]  J. Ross,et al.  Effects of Drugs and of Counterpulsation on Myocardial Oxygen Consumption: Observations on the Ischemic Heart , 1969 .